Peter Altman

Peter Altman

Director Ejecutivo en BIOCARDIA, INC. .

Fortuna: 277 387 $ al 31/05/2026

59 años
Health Technology
Consumer Services

Perfil

Peter Alan Altman was the founder of CareDx, Inc., founded in 1998, where the title held was Director from 2003 to 2014.
Dr. Altman was the founder of Lumen Therapeutics, founded in 2004, where the title held was Chief Executive Officer from 2004 to 2005.
Dr. Altman is also the founder of Sinus Rhythm Technologies, Inc...
Dr. Altman is currently President, Chief Executive Officer & Director at BioCardia, Inc. since 2002.
Dr. Altman is Chief Executive Officer at BioCardia Lifesciences, Inc. Dr. Altman is Director at Oncocyclist Biotech since 2018.
Former jobs include President, Chief Executive Officer & Director at BioCardia, Inc. and Principal at Ventritex, Inc. Education includes a doctorate from the University of California, Berkeley, a doctorate from The University of California, San Francisco, and undergraduate and graduate degrees from Fu Foundation School of Engineering & Applied Science.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
09/06/2026 298.266 ( 2,62 % ) 277 387 $ 31/05/2026

Cargos activos de Peter Altman

EmpresasCargoInicio
BIOCARDIA, INC. Director Ejecutivo 01/01/2002
Oncocyclist Biotech
Director/Miembro de la Junta 01/01/2018
Director Ejecutivo -

Antiguos cargos conocidos de Peter Altman.

EmpresasCargoFin
CAREDX, INC. Fundador 01/01/2014
Director Ejecutivo 01/01/2005
Director Ejecutivo -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Peter Altman.

Formación de Peter Altman.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

32

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Oncocyclist Biotech

ÚLTIMAS HORA | -40%. Las herramientas más útiles solo para suscriptores: ¡descubre las mejores inversiones del futuro!
d
:
:
APROVECHAR LA PROMOCIÓN